Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 17970757)

1.

How to identify patients with vulnerable plaques.

Virani SS, Ballantyne CM.

Diabetes Obes Metab. 2008 Sep;10(10):824-33. Epub 2007 Oct 29. Review.

PMID:
17970757
2.

Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.

Corson MA, Jones PH, Davidson MH.

Am J Cardiol. 2008 Jun 16;101(12A):41F-50F. doi: 10.1016/j.amjcard.2008.04.018. Review.

PMID:
18549871
3.

From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events.

Cola C, Clementi E, Biondi-Zoccai G, Sangiorgi G.

Acta Chir Belg. 2007 Mar-Apr;107(2):129-42. Review.

PMID:
17515260
4.

How to identify the asymptomatic high-risk patient?

Schuijf JD, Achenbach S, Zoghbi WA, Boersma E, Raggi P, Weber M, Nagel E, Narula J, Wackers FJ, Poldermans D, Bax JJ.

Curr Probl Cardiol. 2009 Nov;34(11):539-77. doi: 10.1016/j.cpcardiol.2009.07.001. Review.

PMID:
19804855
5.

Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.

Malik S, Wong ND.

Expert Rev Cardiovasc Ther. 2009 Mar;7(3):273-80. doi: 10.1586/14779072.7.3.273. Review.

PMID:
19296765
6.

New directions in cardiovascular risk assessment: the role of secondary risk stratification markers.

Wierzbicki AS.

Int J Clin Pract. 2012 Jul;66(7):622-30. doi: 10.1111/j.1742-1241.2012.02956.x. Review.

PMID:
22698414
7.

Novel markers of inflammation in atherosclerosis.

Virani SS, Polsani VR, Nambi V.

Curr Atheroscler Rep. 2008 Apr;10(2):164-70. Review.

PMID:
18417072
8.

The vulnerable patient: refocusing on the plaque?

Eijgelaar WJ, Heeneman S, Daemen MJ.

Thromb Haemost. 2009 Aug;102(2):231-9. doi: 10.1160/TH09-01-0030. Review.

PMID:
19652873
9.

Lp-PLA2: a new kid on the block.

Zalewski A, Nelson JJ, Hegg L, Macphee C.

Clin Chem. 2006 Sep;52(9):1645-50. Epub 2006 Jul 27. Review.

10.

Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.

Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL.

Ann Intern Med. 2009 Oct 6;151(7):496-507. Review.

PMID:
19805772
11.

Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.

Anderson JL.

Am J Cardiol. 2008 Jun 16;101(12A):23F-33F. doi: 10.1016/j.amjcard.2008.04.015. Review.

PMID:
18549868
12.

Endothelial dysfunction, vascular disease and stroke: the ARTICO study.

Roquer J, Segura T, Serena J, Castillo J.

Cerebrovasc Dis. 2009;27 Suppl 1:25-37. doi: 10.1159/000200439. Epub 2009 Apr 3. Review.

PMID:
19342831
13.

Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy.

Khakpour H, Frishman WH.

Cardiol Rev. 2009 Sep-Oct;17(5):222-9. doi: 10.1097/CRD.0b013e3181b2434e. Review.

PMID:
19690473
14.

Biomarkers of premature atherosclerosis.

Kampoli AM, Tousoulis D, Antoniades C, Siasos G, Stefanadis C.

Trends Mol Med. 2009 Jul;15(7):323-32. doi: 10.1016/j.molmed.2009.06.001. Epub 2009 Jul 3. Review.

PMID:
19577961
15.

Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus.

Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, Huisman MV, Jukema JW.

Diabetologia. 2008 Sep;51(9):1581-93. doi: 10.1007/s00125-008-1062-4. Epub 2008 Jul 8. Review.

16.

Role of lipoprotein-associated phospholipase A2 in atherosclerosis.

Lavi S, Herrmann J, Lavi R, McConnell JP, Lerman LO, Lerman A.

Curr Atheroscler Rep. 2008 Jun;10(3):230-5. Review.

PMID:
18489851
18.

Lipoprotein-associated phospholipase A2 and risk of stroke.

Gorelick PB.

Am J Cardiol. 2008 Jun 16;101(12A):34F-40F. doi: 10.1016/j.amjcard.2008.04.017. Review.

PMID:
18549870
19.

Measuring subclinical atherosclerosis: is homocysteine relevant?

Sarwar AB, Sarwar A, Rosen BD, Nasir K.

Clin Chem Lab Med. 2007;45(12):1667-77. Review.

PMID:
17990951
20.

Risk assessment in the patient with established peripheral arterial disease.

Haugen S, Casserly IP, Regensteiner JG, Hiatt WR.

Vasc Med. 2007 Nov;12(4):343-50. Review.

PMID:
18048472
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk